Delivery Order SPE2DB20D3103-SPE2DB25FQ1T7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,285.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, commonly utilized in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials valued at $40,827.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting an open competition award. The order is scheduled for completion by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. This competitively awarded, non-set-aside contract has a ceiling value of $2,111.38 and a delivery deadline of August 4, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The contract utilizes firm fixed pricing...
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $2,321.19 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric iron supplement procurement supporting federal medical supply requirements. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,126.04, is for the supply of Ferumoxytol 510 mg/17 ml vials to support federal healthcare programs. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,012.72 contract is for the supply of 510 mg/17 ml vials of the iron supplement Ferumoxytol, with a period of performance through April 2025. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1T7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials totaling $16,217.68 with completion by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used in clinical settings, reflecting the pharmaceutical supply needs of military and federal healthcare systems supported by the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial federal contracting portfolio with the Defense Logistics Agency, fulfilling critical medical supply requirements across multiple therapeutic domains for military healthcare programs, the Defense Health Agency, and other federal healthcare systems worldwide. The contractor's demonstrated capability to meet competitive federal procurement standards and its comprehensive IDC vehicle position it as a key supplier for specialized pharmaceutical products to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/5/25 |